| 000 | 01549 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513193037.0 | ||
| 264 | 0 | _c19991029 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0918-8959 | ||
| 024 | 7 |
_a10.1507/endocrj.46.443 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSato, K | |
| 245 | 0 | 0 |
_aClinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. _h[electronic resource] |
| 260 |
_bEndocrine journal _cJun 1999 |
||
| 300 |
_a443-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmiodarone _xadverse effects |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntithyroid Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothyroidism _xchemically induced |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethimazole _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aThyrotoxicosis _xblood |
| 650 | 0 | 4 |
_aThyrotropin _xblood |
| 650 | 0 | 4 |
_aThyroxine _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriiodothyronine _xblood |
| 700 | 1 | _aMiyakawa, M | |
| 700 | 1 | _aEto, M | |
| 700 | 1 | _aInaba, T | |
| 700 | 1 | _aMatsuda, N | |
| 700 | 1 | _aShiga, T | |
| 700 | 1 | _aOhnishi, S | |
| 700 | 1 | _aKasanuki, H | |
| 773 | 0 |
_tEndocrine journal _gvol. 46 _gno. 3 _gp. 443-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj.46.443 _zAvailable from publisher's website |
| 999 |
_c10461091 _d10461091 |
||